Pharmacoeconomics
TABLE OF CONTENTS
Volume 84, Issue 2 (August 2008)
Editorial |
News & Views |
Perspectives |
Research |
Discovery & Development |
Regulation & Use
In This Issue
In This Issue
In This Issue
Clin Pharmacol Ther 84: 177; doi:10.1038/clpt.2008.137
See also: Macroscopy by Pizzi & SinghSee also: Article by Hamrén et al. See also: Article by Kim et al. See also: Discovery by Sollano et al. See also: Practice by Wu & FuhlbriggeEditorial
Editorial
Pharmacoeconomics in the Era of Individualized Medicine
SA Waldman and A Terzic
Clin Pharmacol Ther 84: 179-182; doi:10.1038/clpt.2008.142
News & Views
Highlights
Highlights
Clin Pharmacol Ther 84: 184-185; doi:10.1038/clpt.2008.136
ASCPT News
ASCPT News
Clin Pharmacol Ther 84: 186-187; doi:10.1038/clpt.2008.138
Macroscopy
Pharmacoeconomics Is Coming of Age
LT Pizzi and VP Singh
Clin Pharmacol Ther 84: 188-190; doi:10.1038/clpt.2008.120
See also: Commentary by HayPerspectives
Commentaries
Harnessing Economic Drivers for Successful Clinical Implementation of Pharmacogenetic Testing
PA Deverka and HL McLeod
Clin Pharmacol Ther 84: 191-193; doi:10.1038/clpt.2008.121
Nonprofit Biomedical Companies
RM Conti, DO Meltzer and MJ Ratain
Clin Pharmacol Ther 84: 194-197; doi:10.1038/clpt.2008.123
Using Pharmacoeconomics to Value Pharmacotherapy
JW Hay
Clin Pharmacol Ther 84: 197-200; doi:10.1038/clpt2008124
See also: Macroscopy by Pizzi & SinghThe European ACuteTox Project: A Modern Integrative In Vitro Approach to Better Prediction of Acute Toxicity
C Clemedson
Clin Pharmacol Ther 84: 200-202; doi:10.1038/clpt.2008.135
Letters to the Editor
The Unanswered Question: What Is the Determinant of S-1 Pharmacokinetics?
W Ichikawa, K Fujita and Y Sasaki
Clin Pharmacol Ther 84: 203; advance online publication, March 26, 2008; doi:10.1038/clpt.2008.60
Response to "The Unanswered Question: What Is the Determinant of S-1 Pharmacokinetics?"
Y Kaida, N Inui, T Suda, H Watanabe and K Chida
Clin Pharmacol Ther 84: 204; advance online publication, April 30, 2008; doi:10.1038/clpt.2008.81
Research
Communications
CYP3A5 Genotype Has No Impact on Plasma Trough Concentrations of Lopinavir and Ritonavir in HIV-infected Subjects
RCE Estrela, AB Santoro, PF Barroso, M Tuyama and G Suarez-Kurtz
Clin Pharmacol Ther 84: 205-207; advance online publication, February 20, 2008; doi:10.1038/clpt.2008.12
Reports
Effects of Selective vs. Nonselective Cyclooxygenase Inhibition on Dynamic Renal Potassium Excretion: A Randomized Trial
RA Preston, D Afshartous and AB Alonso
Clin Pharmacol Ther 84: 208-211; advance online publication, February 27, 2008; doi:10.1038/clpt.2008.16
Early and Accurate Prediction of Peg-IFNs/Ribavirin Therapy Outcome in the Individual Patient With Chronic Hepatitis C by Modeling the Dynamics of the Infected Cells
P Colombatto, P Ciccorossi, AM Maina, L Civitano, F Oliveri, B Coco, V Romagnoli, F Bonino and MR Brunetto
Clin Pharmacol Ther 84: 212-215; advance online publication, March 19, 2008; doi:10.1038/clpt.2008.21
Articles
Development of Procedures for Early Screening of Smoking Cessation Medications in Humans
KA Perkins, C Lerman, ML Stitzer, CA Fonte, JL Briski, JA Scott and KNR Chengappa
Clin Pharmacol Ther 84: 216-221; advance online publication, March 19, 2008; doi:10.1038/clpt.2008.30
Effect of APOE Genotype on Lipid Levels in Patients With Coronary Heart Disease During a 3-Week Inpatient Rehabilitation Program
CY Vossen, MM Hoffmann, H Hahmann, B Wüsten, D Rothenbacher and H Brenner
Clin Pharmacol Ther 84: 222-227; advance online publication, March 19, 2008; doi:10.1038/clpt.2008.31
Models for Plasma Glucose, HbA1c, and Hemoglobin Interrelationships in Patients with Type 2 Diabetes Following Tesaglitazar Treatment
B Hamrén, E Björk, M Sunzel and MO Karlsson
Clin Pharmacol Ther 84: 228-235; advance online publication, March 19, 2008; doi:10.1038/clpt.2008.2
The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel Resistance
KA Kim, PW Park, SJ Hong and J-Y Park
Clin Pharmacol Ther 84: 236-242; advance online publication, March 5, 2008; doi:10.1038/clpt.2008.20
Genetic Influences in the Variation in Renal Clearance of Nicotine and Cotinine
NL Benowitz, CN Lessov-Schlaggar and GE Swan
Clin Pharmacol Ther 84: 243-247; advance online publication, April 2, 2008; doi:10.1038/clpt.2008.54
Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study
MF Hebert, TR Easterling, B Kirby, DB Carr, ML Buchanan, T Rutherford, KE Thummel, DP Fishbein and JD Unadkat
Clin Pharmacol Ther 84: 248-253; advance online publication, February 20, 2008; doi:10.1038/clpt.2008.1
Renal Function as a Predictor of Irinotecan-induced Neutropenia
FA de Jong, JM van der Bol, RHJ Mathijssen, T van Gelder, EAC Wiemer, A Sparreboom and J Verweij
Clin Pharmacol Ther 84: 254-262; advance online publication, February 20, 2008; doi:10.1038/sj.clpt.6100513
Discovery & Development
Discovery
The Economics of Drug Discovery and the Ultimate Valuation of Pharmacotherapies in the Marketplace
JA Sollano, JM Kirsch, MV Bala, MG Chambers and LH Harpole
Clin Pharmacol Ther 84: 263-266; advance online publication, June 11, 2008; doi:10.1038/clpt.2008.117
Development
Optical Molecular Imaging: From Single Cell to Patient
EH Moriyama, G Zheng and BC Wilson
Clin Pharmacol Ther 84: 267-271; advance online publication, April 2, 2008; doi:10.1038/clpt.2008.58
Regulation & Use
Practice
Economic Evaluation of Pharmacogenetic Tests
AC Wu and AL Fuhlbrigge
Clin Pharmacol Ther 84: 272-274; advance online publication, June 25, 2008; doi:10.1038/clpt.2008.127
Ethics
How Should Adverse Events Be Reported in US Clinical Trials?: Ethical Considerations
AE Shamoo and LI Katzel
Clin Pharmacol Ther 84: 275-278; advance online publication, February 27, 2008; doi:10.1038/clpt.2008.14
Public Policy
Pharmacoeconomics Comes of Age?
T Walley and A Breckenridge
Clin Pharmacol Ther 84: 279-280; advance online publication, June 18, 2008; doi:10.1038/clpt.2008.122
Education
The Use of Patient-Reported Outcome Measures in the Evaluation of Medical Products for Regulatory Approval
LB Burke, DL Kennedy, PH Miskala, EJ Papadopoulos and AM Trentacosti
Clin Pharmacol Ther 84: 281-283; advance online publication, June 25, 2008; doi:10.1038/clpt.2008.128
